Avenue Therapeutics, Inc. Profile Avatar - Palmy Investing

Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in…

Biotechnology
US, New York [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ATXI's Analysis
CIK: 1644963 CUSIP: 05360L205 ISIN: US05360L3042 LEI: - UEI: -
Secondary Listings
ATXI has no secondary listings inside our databases.